Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma | Journal of Hematology & Oncology | Full Text
New immunotherapy sends multiple myeloma into remission
CAR T-Cell Therapy Approved for Multiple Myeloma - NCI
Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell Leukemia: Molecular Therapy
CAR T cell therapies for patients with multiple myeloma | Nature Reviews Clinical Oncology
Ask The Nurse: CAR-T cell treatments - Myeloma UK
Frontiers | Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
Beyond our wildest dreams' – CAR-T therapies in multiple myeloma - The Pharmaceutical Journal
Frontiers | Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management Strategies
FDA Approves Carvykti CAR T-Cell Therapy for Multiple Myeloma - NCI
Frontiers | CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
New CAR T-cell therapy extends remission in heavily relapsed multiple myeloma patients: Newsroom - UT Southwestern, Dallas, Texas
CAR T-Cell Therapy for Multiple Myeloma - NCI
CAR T-cell therapy in multiple myeloma: more room for improvement | Blood Cancer Journal
Chimeric antigen receptor (CAR)-T cells from multiple myeloma (MM)... | Download Scientific Diagram
CAR T-cell therapy in multiple myeloma: more room for improvement | Blood Cancer Journal
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism | Stem Cell Research & Therapy | Full Text
CAR T-cell therapy for multiple myeloma: state of the art and prospects - The Lancet Haematology
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma | Gene Therapy
CAR T-cell therapy for patients with multiple myeloma | BLCTT
CAR T-cell therapy in multiple myeloma: more room for improvement | Blood Cancer Journal
The application of CAR-T cell therapy in hematological malignancies: advantages and challenges - ScienceDirect
